BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
92.76
-0.05 (-0.05%)
Aug 11, 2026, 10:10 AM EDT - Market open

BioNTech SE Balance Sheet

Millions EUR. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
9,7417,6759,76211,66413,8751,693
Short-Term Investments
5,0387,2027,0224,885189.4381.6
Cash & Short-Term Investments
14,77914,87716,78416,54914,0652,074
Cash Growth
5.29%-11.36%1.42%17.66%578.04%53.95%
Accounts Receivable
163.9924.21,4642,1567,14612,382
Other Receivables
10.48.1104.9--
Total Trade Receivables
174.3932.31,4742,1617,14612,382
Inventory
100.6110.7283.3357.7439.6502.5
Other Current Assets
243.6226.4262.7460272.3113.8
Total Current Assets
15,29716,14718,80419,52721,92215,072
Net Property, Plant & Equipment
1,2181,2911,183971.6821.1520.4
Other Intangible Assets
1,4221,606790.4804.1158.5202.4
Goodwill
373.3367.9380.6362.561.2-
Long-Term Investments
2,0062,5541,2541,17680.221.3
Other Long-Term Assets
2622.8117.8164.7236.114.4
Total Assets
20,34321,98922,53023,00623,27915,831

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
646.7534.9426.7354204.1160
Accrued Expenses
234.9145.3144.8269.3367.2110.2
Current Portion of Leases
57.252.239.528.136129.9
Unearned Revenue
742.5754.9294.9353.3101.5276.1
Other Current Liabilities
267.96551,6171,0662,2422,805
Total Current Liabilities
1,9492,1422,5232,0712,9513,482
Long-Term Leases
258.9215.2214.7191176.2171.6
Other Long-Term Liabilities
377406.9380.7498.996.7283.9
Total Long-Term Liabilities
635.9622.1595.4689.9272.9455.5
Total Liabilities
2,5852,7643,1192,7603,2243,937

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
259259248.6248.6248.6246.3
Treasury Stock
-7.8-7.7-8.6-10.8-5.3-3.8
Additional Paid-in Capital
2,3392,4731,3991,2291,8281,674
Accumulated Other Comprehensive Income
-1,442-1,462-1,326-984.6-848.993.9
Retained Earnings
16,60917,96219,09819,76318,8339,883
Shareholders' Equity
17,75819,22419,41120,24620,05611,894
Total Liabilities & Equity
20,34321,98922,53023,00623,27915,831

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
316.1267.4254.2219.1212.2301.5
Net Cash (Debt)
14,46314,61016,52916,33013,8521,773
Net Cash Growth
5.05%-11.61%1.22%17.89%681.38%60.10%
Net Cash Per Share
57.5560.4568.7667.2855.456.83
Book Value
17,75819,22419,41120,24620,05611,894
Book Value Per Share
70.6679.5480.7583.4280.2945.80
Tangible Book Value
15,96317,25018,24019,07919,83611,691
Tangible Book Value Per Share
63.5171.3775.8778.6179.4145.02
SEC Filings: 10-K · 10-Q